AU11 Xanthohumol Benefits and Availability

Have a look at our PowerPoint Introduction and Brochure describing deliverables, differentiators and case studies. Eight case studies can also be reviewed.

Method

    The main contents of the study were based on sources including in-house databases and an extensive network of contacts in addition to publicly available information (e.g. data from government agencies, patents, scientific journals, trade press, internet etc.). Additional information was sought from other key resources within the industries concerned in sufficient depth to provide accurate analysis and guidance.
    CPL used its extensive network of contacts, (including the CPL Executive Search network), to elicit information that would be difficult or impossible for clients to obtain independently Interviews were conducted with those knowledgeable in the industry, both face-to-face and telephone conversations. Contacts were also made at trade-shows.
    The report consists of two parts, the summary report and the reference report, to provide the essence of CPL’s findings along with our recommendations, followed by detailed data sources and analysis.

Table of Contents

Principal Findings

    PUReOPE Opportunities with Xanthohumol and Related Compounds
    Supply
    Players Products and Patent Applications
    Health Related Benefits
    Conclusions
    Recommendations

Background

    Aging Related Disease
    XN and Derivatives as an in Vivo Antioxidant
    Xanthohumol

11 Hop Players and Suppliers

    Products and Pricing

Recent Articles and News

    Nematodes and Polyphenols
    3 Articles
    Microbial and Dietary Activation
    10 Articles
    Cognitive Impairment
    8 Articles
    Metabolic Syndrome
    8 Articles
    Phytoestrogen
    4 Articles
    Tissue Related Inflamation
    4 Articles
    Adaptive Inflammation
    4 Articles
    Therapeutics
    7 Articles

Patents

    4 Tables

      6 Figures

CPL Gallery

Previous Image
Next Image